| MYRIAD GENETICS DL-,01 |
| USA |
| Gesundheit |
| US62855J1043 / 897518 |
| MYD (Frankfurt) / MYGN (NASDAQ) |
| FRA:MYD, ETR:MYD, MYD:GR, NASDAQ:MYGN |
| - |
| https://myriad.com/ |
|
Myriad Genetics Inc. is a biotechnology company sp..
>Volltext.. |
| 533.27 Mio. EUR |
| 590.33 Mio. EUR |
| 704.7 Mio. EUR |
| -22.2 Mio. EUR |
| -341.98 Mio. EUR |
| -3.7 EUR |
| 181.28 Mio. EUR |
| 124.15 Mio. EUR |
| -1.88 Mio. EUR |
| 0.98 |
| -4.92% |
| -227.6% |
| - |
| - |
| - |
| - |
| MYRIAD GENETICS |
| 22.12.25 |
|